Clinical Trial Update: Effects of HMG-coA Reductase Inhibitor on Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of a statin (HMG-CoA reductase inhibitor) on rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• HMG-CoA reductase inhibitor

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED